196 related articles for article (PubMed ID: 1397042)
1. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
Bui JD; Kimura B; Phillips MI
Eur J Pharmacol; 1992 Aug; 219(1):147-51. PubMed ID: 1397042
[TBL] [Abstract][Full Text] [Related]
2. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
Hogarty DC; Speakman EA; Puig V; Phillips MI
Brain Res; 1992 Jul; 586(2):289-94. PubMed ID: 1521162
[TBL] [Abstract][Full Text] [Related]
3. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
Culman J; von Heyer C; Piepenburg B; Rascher W; Unger T
Eur J Pharmacol; 1999 Feb; 367(2-3):255-65. PubMed ID: 10079000
[TBL] [Abstract][Full Text] [Related]
4. Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat.
Kirby RF; Thunhorst RL; Johnson AK
Brain Res; 1992 Apr; 576(2):348-50. PubMed ID: 1515929
[TBL] [Abstract][Full Text] [Related]
5. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
Polidori C; Ciccocioppo R; Pompei P; Cirillo R; Massi M
Eur J Pharmacol; 1996 Jul; 307(3):259-67. PubMed ID: 8836613
[TBL] [Abstract][Full Text] [Related]
6. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
Morita O; Kushida H; Kunihara M
J Cardiovasc Pharmacol; 1995 Jun; 25(6):880-7. PubMed ID: 7564332
[TBL] [Abstract][Full Text] [Related]
7. Functional evidence that the angiotensin antagonist losartan crosses the blood-brain barrier in the rat.
Li Z; Bains JS; Ferguson AV
Brain Res Bull; 1993; 30(1-2):33-9. PubMed ID: 8420632
[TBL] [Abstract][Full Text] [Related]
8. Functional role of brain AT1 and AT2 receptors in the central angiotensin II pressor response.
Toney GM; Porter JP
Brain Res; 1993 Feb; 603(1):57-63. PubMed ID: 8453478
[TBL] [Abstract][Full Text] [Related]
9. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.
Toney GM; Porter JP
Neuropharmacology; 1993 Jun; 32(6):581-9. PubMed ID: 8336821
[TBL] [Abstract][Full Text] [Related]
10. Cerebroventricular injection of angiotensin II antagonist: effects on blood pressure responses to central and systemic angiotensin II.
Gorbea-Oppliger VJ; Fink GD
J Pharmacol Exp Ther; 1995 May; 273(2):611-6. PubMed ID: 7752062
[TBL] [Abstract][Full Text] [Related]
11. The role of angiotensin AT1 receptors in the diuretic, natriuretic, kaliuretic and blood pressure responses induced by angiotensin II activation of the median preoptic nucleus in conscious rats.
Ferreira-do-Vale C; Renzi A; Camargo GP; Saad WA; Luiz AC; Menani JV; Silveira JE; Camargo LA
Braz J Med Biol Res; 1995 Oct; 28(10):1097-101. PubMed ID: 8634683
[TBL] [Abstract][Full Text] [Related]
12. Losartan inhibition of angiotensin-related drinking and Fos immunoreactivity in hypertensive and hypotensive contexts.
Rowland NE; Morien A; Fregly MJ
Brain Res; 1996 Dec; 742(1-2):253-9. PubMed ID: 9117402
[TBL] [Abstract][Full Text] [Related]
13. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
Toney GM; Porter JP
Brain Res Dev Brain Res; 1993 Feb; 71(2):193-9. PubMed ID: 8491041
[TBL] [Abstract][Full Text] [Related]
14. The role of brain angiotensin in thirst and AVP release induced by hemorrhage.
Phillips MI; Heininger F; Toffolo S
Regul Pept; 1996 Oct; 66(1-2):3-11. PubMed ID: 8899885
[TBL] [Abstract][Full Text] [Related]
15. Acute and chronic effects of losartan (DuP 753) on blood pressure and vascular reactivity in normotensive rats.
Soltis EE; Jewell AL; Dwoskin LP; Cassis LA
Clin Exp Hypertens; 1993 Jan; 15(1):171-84. PubMed ID: 8467311
[TBL] [Abstract][Full Text] [Related]
16. Competitive antagonism of pressor responses to angiotensin II and angiotensin III by the angiotensin II-1 receptor ligand losartan.
Abdelrahman A; Pang CC
Can J Physiol Pharmacol; 1992 May; 70(5):716-9. PubMed ID: 1423014
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
Christ DD; Wong PC; Wong YN; Hart SD; Quon CY; Lam GN
J Pharmacol Exp Ther; 1994 Mar; 268(3):1199-205. PubMed ID: 8138932
[TBL] [Abstract][Full Text] [Related]
18. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats.
Bunting MW; Widdop RE
Br J Pharmacol; 1995 Dec; 116(8):3181-90. PubMed ID: 8719794
[TBL] [Abstract][Full Text] [Related]
19. Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.
Song KF; Zhuo JL; Mendelsohn FA
Br J Pharmacol; 1991 Dec; 104(4):771-2. PubMed ID: 1810594
[TBL] [Abstract][Full Text] [Related]
20. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
Siegl PK; Chang RS; Mantlo NB; Chakravarty PK; Ondeyka DL; Greenlee WJ; Patchett AA; Sweet CS; Lotti VJ
J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
